2024
|
Invention
|
Composition for subcutaneous administration comprising hyaluronidase polypeptide and drug. The pr... |
2022
|
Invention
|
Hyaluronidase polypeptide and use thereof. The present invention relates to a hyaluronidase polyp... |
2021
|
Invention
|
Composition, for osteoarthritis treatment, comprising hydrophilized sulfasalazine and hyaluronic ... |
2019
|
P/S
|
Immunostimulants; Pharmaceutical products for the treatment of viral diseases; Pharmaceutical pre... |
2017
|
Invention
|
Hemostatic composition comprising cross-linked hyaluronic acid derivative matrix. The present inv... |
|
Invention
|
Hemostasis composition including cross-linking hyaluronic acid derivative matrix. The present inv... |
|
Invention
|
Stabilizer for hyaluronidase and liquid formulation comprising hyaluronidase.
This invention rel... |
2016
|
Invention
|
Composition for injection of hyaluronic acid, containing hyaluronic acid derivative and dna fract... |
2013
|
Invention
|
Stabilizer for hyaluronidase and liquid formulation comprising hyaluronidase. 2. The liquid formu... |
|
Invention
|
Stabilizer for hyaluronidase and liquid formulation comprising hyaluronidase. This invention rela... |
2012
|
Invention
|
Composition for inhibiting after-cataract and method of preparing the same. The present invention... |
|
Invention
|
Composition for inhibiting after-cataract and method for preparing same. The present invention re... |